← Insider buys
SCMP

Sucampo Pharmaceuticals, Inc.

CEO Peter Greenleaf sold $3.4M of Sucampo Pharmaceuticals, Inc.

Sold$3,368,807
$16.84Price
200,000Shares
−99%Stake

What SCMP did after the filing

Prices for SCMP after this filing aren't in yet.

Traded Mon, Nov 28. Filed Wed, Nov 30, 4:01 PM ET, after the close. Not investment advice.